The Central and Basolateral Amygdala Are Critical Sites of Neuropeptide Y/Y2 Receptor-Mediated Regulation of Anxiety and Depression
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Anxiety is integrated in the amygdaloid nuclei and involves the interplay of the amygdala and various other areas of the brain. Neuropeptides play a critical role in regulating this process. Neuropeptide Y (NPY), a 36 aa peptide, is highly expressed in the amygdala. It exerts potent anxiolytic effects through cognate postsynaptic Y1 receptors, but augments anxiety through presynaptic Y2 receptors. To identify the precise anatomical site(s) of Y2-mediated anxiogenic action, we investigated the effect of site-specific deletion of the Y2 gene in amygdaloid nuclei on anxiety and depression-related behaviors in mice. Ablating the Y2 gene in the basolateral and central amygdala resulted in an anxiolytic phenotype, whereas deletion in the medial amygdala or in the bed nucleus of the stria terminalis had no obvious effect on emotion-related behavior. Deleting the Y2 receptor gene in the central amygdala, but not in any other amygdaloid nucleus, resulted in an added antidepressant-like effect. It was associated with a reduction of presumably presynaptic Y2 receptors in the stria terminalis/bed nucleus of the stria terminalis, the nucleus accumbens, and the locus ceruleus. Our results are evidence of the highly site-specific nature of the Y2-mediated function of NPY in the modulation of anxiety- and depression-related behavior. The activity of NPY is likely mediated by the presynaptic inhibition of GABA and/or NPY release from interneurons and/or efferent projection neurons of the basolateral and central amygdala.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 1×
“This test was performed to assess depression-like behavior, as described previously (Steru et al., 1985; Tasan et al., 2009).”
MethodLeDoux, J., Iwata, J., Cicchetti, P., & Reis, D. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02517.1988 · Cited by 1,580
Swanson, L. W., & Petrovich, G. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01265-x · Cited by 1,351
Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F., & Hen, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3632-07.2008 · Cited by 550
Grimm, D., Kay, M. A., & Kleinschmidt, J. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00095-9 · Cited by 344 · cited 2×
“rAAV vectors For rAAV-mediated expression of Cre-GFP, or GFP alone as a control, rAAV serotype 2-based vectors pseudotyped with rAAV serotype 1 capsid proteins (rAAV-2/1) were prepared by a two plasmid cotransfection procedure using HEK293 cells (Grimm et al., 2003).”
BackgroundMethodBodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989) · Psychopharmacology · doi:10.1007/bf00442264 · Cited by 221
Tasan, R. O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H., & Sperk, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.048 · Cited by 71 · cited 3×
“The open field test was performed to measure overall motor activity, and was performed as described previously (Hall, 1934; Tschenett et al., 2003; Tasan et al., 2009).”
MethodSajdyk, T., Johnson, P., Fitz, S., & Shekhar, A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082902 · Cited by 66
Cited by
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501
“The anxiolytic and antidepressant action of Y2 receptor knockout has been localised to the deletion of presynaptic Y2 receptors in the central and basolateral amygdala (Tasan et al., 2010).”
Neuropeptide Y: a stressful review
Reichmann, F., & Holzer, P. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.008 · Cited by 490
Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain
Hörtnagl, H., Tasan, R. O., Wieselthaler, A., Kirchmair, E., Sieghart, W., & Sperk, G. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.008 · Cited by 229
“Brains were either snap frozen (isopentane, 70 C, 3 min) for ISH or perfused with 4% paraformaldehyde for IHC (Tasan et al., 2010).”
MethodInfluentialSelf-citationNeuropeptide Y and posttraumatic stress disorder
Sah, R., & Geracioti, T. D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.101 · Cited by 166
The role of NPY in learning and memory
Gøtzsche, C. R., & Woldbye, D. P. D. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.010 · Cited by 165
“…that NPY ligands can influence emotional behaviours (via Y1, Y2, Y4, and Y5; Kask et al., 2002; Redrobe et al., 2002; Sørensen et al., 2004; Tasan et al., 2009, 2010; MoralesMedina et al., 2010), motivational feeding behaviour (Berglund et al., 2003), as well as locomotor activity and…”
Metadata
- Authors
- Tasan, R. O., Nguyen, N. K., Weger, S., Sartori, S. B., Singewald, N., Heilbronn, R., Herzog, H., & Sperk, G.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-05-05
- Volume
- 30
- Issue
- 18
- Pages
- 6282-6290
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1970321055
- Cited by
- 152
- References
- 8
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.